As the situation with coronavirus (COVID-19) develops, we want to do all we can to ensure the safety of our people, our clients, and their families while still offering an uninterrupted and full service to our clients.
We are continuing to follow government advice regarding remote and socially distanced working, and we are currently holding client meetings and events online and/or by phone where possible.
Our strengths lie in the life sciences, tech, media and comms, renewable energy, financial services and real estate sectors. Domestically, our experience covers the range of legal disciplines, including dispute resolution, employment and real estate.
We are also well known for advising on major cross-border transactions, both inbound and for Spanish and Latin American clients, and on numerous high-profile international M&A transactions and investments.
Micro and small companies, including start-ups, may benefit from aid; while recapitalisation measures have been modified for businesses in general.
Advised Scranton Enterprises on acquisition financing for its purchase of Grifols companies Biotest and Haema as part of $537m sale, read more.
Advised The Entertainer on its first full acquisition in Europe, read more.
Advised Grifols on the €1.7 billion acquisition of Hologic's blood screening business.
